Human Tumor Necrosis Factor Receptor (TNFR1) L-ELISA quantifies Hu TNFR1 in human serum, plasma, buffered solution or human cell culture medium. The dosage will recognize exclusively the human TNFR1...
Human Tumor Necrosis Factor Receptor (TNFR1) L-ELISA quantifies Hu TNFR1 in human serum, plasma, buffered solution or human cell culture medium. The dosage will recognize only natural and recombinant human TNFR1. Principle of the solid phase L-ELISA sandwich method of human TNFR1 (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-assembled in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bind to the immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
Tumor Necrosis Factor (TNFR1) receptor 1 belongs to the tumour necrosis factor superfamily and is one of the major TNF-alpha receptors. This receptor plays an important role in mediating apoptosis. TNFR1 also plays an important role in cytokine-moderate signaling, positive regulation of the NF-Kb pathway, positive regulation of angiogenesis, and negative regulation of genetic expression. The extracellular domain of the receptor is also released into the circulatory system as soluble TNFR1 (sTNFR1). In humans, the TNFR1 gene is located on chromosome 12. Order information
Shipping conditions : dry ice
Sensitivity
Sensitivity of the dosage: 50 pg/ml.
Measurement range
Dose range: 1-47 ng/ml.
Duration of dosing
Total duration of dosing: 1 h 15 min.
Reproducibility
Coefficient of intradose variation 4.6%, interdose 7.3%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 10511475 |
| Specifications |
| Accession number | P19438 |
| Dose range | 1-47 ng/ml |
| Sensitivity of the dosage | 50 pg/ml |
| Conjugate | HRP |
| Product type | Kit ELISA |
| Type of sample | Serum, Surnatant, Surnatant |
| Target species | Human |
| For use with (application) | Colorimetric detection |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 7132 |
| Gene symbol(s) | CD120a,FPF,TBP1,TNF-R,TNF-R-I,TNF-R55,TNFAR,TNFR1,TNFR55,TNFR60,p55,p55-R,p60 |
| Incubation time | 1.25 h |
| Coefficient of inter-dose variation | 7.3% |
| Coefficient of intra-dose variation | 4.6% |
| Contents of kits | 96-well pre-coated plate, Calibration, Standard dilution stamp, Incubation stamp, HRP conjugate detection antibody, Wash pad, Chromogen, Stop solution, isotypic |
| Marker or dye | HRP |
| Genetic marker | TNF-RI |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 50 μl; Serum, 50 μl; Supernatant, 50 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 1 h 15 min |
Origin and customs
| Manufacturer ref. | KAC1761 |
|---|
| Country of origin | United Kingdom |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.